News | Radiation Therapy | March 04, 2016

Software will be used to handle dose accumulation, contour creation, image fusion and other clinical and research work

March 4, 2016 — MIM Software Inc. has recently collaborated with Memorial Sloan Kettering Cancer Center (MSK), nationally recognized by the National Cancer Institute and ranked by U.S. News & World Report as one of the top hospitals for cancer care in the country.

MSK will be using MIM Software's radiation oncology solution as a software source for handling dose accumulation, contour creation, image fusions and deformable registrations, as well as a host of other clinical and research work. The software will be deployed at the main campus in Manhattan, along with all outpatient facilities that extend from Manhattan through the New York suburbs as well as New Jersey and Long Island.

"In the ever increasing world of complex treatments for cancer, we are always looking to enhance our clinical workflow and advance the research we do," said Sandra Fontenla, senior physicist-clinical coordinator for external beam at MSK.

"Radiation therapy has become increasingly reliant on imaging for the safe and accurate treatment of cancer," Fontenla continues. "Our goal is to accomplish faster and more precise image registrations to enable physicians to identify tumors more quickly and accurately."

For more information: www.mimsoftware.com


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
Subscribe Now